Galmed Pharmaceuticals

NASH on the Cusp: An Emerging Market Opportunity
BioSpace
Mon, 10/23/23 - 09:53 am
NASH
Viking Therapeutics
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Akero Therapeutics
Hepion Pharmaceuticals
Novo Nordisk
Galmed Pharmaceuticals
NASH: Wall Street’s Forgotten Mega Blockbuster Indication
BioSpace
Mon, 12/12/22 - 10:13 am
NASH
Intercept Pharma
Novo Nordisk
Madrigal Pharmaceuticals
Inventiva
Galmed Pharmaceuticals
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 06/16/18 - 09:50 pm
Galmed Pharmaceuticals
Galectin
Eloxx Pharmaceuticals
Galmed stock jumps sky-high on mixed results for NASH drug
Biopharma Dive
Thu, 06/14/18 - 09:27 am
Galmed Pharmaceuticals
clinical trials
NASH
aramchol
Biotech: Why NASH is So Hot Right Now
Barron's
Wed, 09/21/16 - 10:55 pm
NASH
Allergan
M&A
Gilead Sciences
Tobira Therapeutics
Galmed Pharmaceuticals
Gilead's Next Logical Acquisition, Part 1: NASH And Galmed
Seeking Alpha
Thu, 10/8/15 - 12:21 pm
Gilead Sciences
M&A
Galmed Pharmaceuticals
NASH
Galmed Pharmaceuticals: A Compelling Trade For Your New Year Portfolio
Seeking Alpha
Sun, 12/28/14 - 09:00 am
Galmed Pharmaceuticals
After hep C cure, companies target next big liver disease market
Yahoo/Reuters
Sun, 11/9/14 - 09:46 am
hepatitis B
hepatitis
nonalcoholic steatohepatitis
Gilead
Galmed Pharmaceuticals
Raptor Pharmaceuticals
Conatus Pharmaceuticals
Biotechs Post Better Returns This Week Before An IPO Tech Wave
Seeking Alpha
Fri, 03/14/14 - 08:35 am
IPOs
Achaogen
Dipexium Pharmaceuticals
Galmed Pharmaceuticals
Recro Pharma
Aquinox Pharmaceuticals